Nucleic acid drug vectors for diagnosis and treatment of brain diseases.
Ontology highlight
ABSTRACT: Nucleic acid drugs have the advantages of rich target selection, simple in design, good and enduring effect. They have been demonstrated to have irreplaceable superiority in brain disease treatment, while vectors are a decisive factor in therapeutic efficacy. Strict physiological barriers, such as degradation and clearance in circulation, blood-brain barrier, cellular uptake, endosome/lysosome barriers, release, obstruct the delivery of nucleic acid drugs to the brain by the vectors. Nucleic acid drugs against a single target are inefficient in treating brain diseases of complex pathogenesis. Differences between individual patients lead to severe uncertainties in brain disease treatment with nucleic acid drugs. In this Review, we briefly summarize the classification of nucleic acid drugs.
SUBMITTER: Lu ZG
PROVIDER: S-EPMC9844208 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA